NRX Pharmaceuticals Inc (NRXP)

[mc67]

$RLFTF $NRXP DD (opinion) post by Jonty on Yh0 - Being a physician, we have been using Tocilizumab very frequently since March and we have seen patients surviving. However the problem is while most don’t die immediately, many of them remain on high amounts of OptiFlow at 60 liters oxygen with 100% FiO2 for long time with no improvement in their respiratory status.

They can’t even talk without getting out of breath. Some end up going on ventilator eventually and either die or end up going for lung transplant. So while Tocilizumab may be preventing immediate deaths, it is not necessarily improving survival as it has no protective effects on lung damage that would still take place. Plus we are starting to see high amounts of fungal infections in patients who have got Tocilizumab.

That is when Aviptadil comes into play. We have seen so many case reports so far with patients making recovery. I sincerely wish that FDA doesn’t get stuck on nitpicking data and delay or deny EUA to this life saving drug. The evidence is overwhelming and I hope so many case reports are not brushed aside as being anecdotal evidence.

Science doesn’t belong to a group of people. It’s open for everyone to contribute & it’s always evolving as we learn new information. So I really hope that these bureaucratic agencies look at it with open mind and approve the drug & stop letting people die. We have waited longer than we should have in the name of trial and data but in the middle of the pandemic, we can’t afford to have a clean & pure data at the expense of people’s lives. Approve it quickly and start saving lives.